Prescription GLP-1 receptor agonists may be indicated for adults with type 2 diabetes not meeting glycemic targets, those with established cardiovascular disease or chronic kidney disease, or individuals with obesity and weight-related complications when lifestyle interventions prove insufficient
But there is another reason dinner demands your attention
| Anshuman Kaushal
So, this is not a unique situation also, Ben, just for these two drugs of Eliquis and Xarelto, I truly believe that every other MFP drug will have significant issues with regards to access because of this increasing out of pocket costs that will occur because PBMs are going to fill the pressure of filling the void from the profitability that theyre going to lose
The effects of GLP-1 medications for weight loss are significant up to an average 22.5% loss of initial body weight on Mounjaro
Further, the complaint alleges that the switches to doses with additives and non-standard doses were not supported by patient exams or medical indications
